PALS

Clinical trials for PALS explained in plain language.

Never miss a new study

Get alerted when new PALS trials appear

Sign up with your email to follow new studies for PALS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for ALS patients: experimental drug CNM-Au8 now available through expanded access

Disease control TEMPORARILY_NOT_AVAILABLE

This program provides early access to an experimental drug called CNM-Au8 for people with amyotrophic lateral sclerosis (ALS), a progressive nerve disease. Participants must be 18 or older with a confirmed ALS diagnosis and able to take the medication by mouth. The goal is to off…

Matched conditions: PALS

Sponsor: Clene Nanomedicine • Aim: Disease control

Last updated May 11, 2026 20:50 UTC

PALS

Get alerted when new PALS trials appear

New hope for ALS patients: experimental drug CNM-Au8 now available through expanded access